2025-04-19 - Analysis Report
## Newmont Corporation (NEM) Stock Review

**0. Key Figures & Initial Analysis:**

Newmont Corporation (NEM) is a leading gold and copper mining company.  The provided data shows a mixed performance, with significant underperformance against the S&P 500 (VOO) but potentially positive indicators in recent earnings and financial information.

**1. Performance Comparison with S&P 500 (VOO):**

* **NEM Cumulative Return:** 47.8%
* **VOO Cumulative Return:** 76.2%
* **Return Difference:** -28.4%  (This indicates NEM underperformed VOO by 28.4% over the measured period).
* **Relative Divergence:** 29.6% (This places the current underperformance at the 29.6th percentile of historical divergence between NEM and VOO).


**Alpha and Beta Analysis:**

The provided alpha and beta values show a fluctuating relationship between NEM and the market.  While alpha is mostly positive indicating outperformance in some periods, the high beta values (particularly in the 2021-2024 period) signify higher than average market sensitivity.  The high negative CAGR in recent years (-37%, -70%, -10%) reflects significant volatility.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 34.0% | 26.5% | 2.0% | -0.0 | 33.9 |
| 2016-2018  | 19.0% | 58.8% | -2.0% | 0.0 | 31.8 |
| 2017-2019  | 4.0% | 58.8% | -29.0% | -0.1 | 41.5 |
| 2018-2020  | 44.0% | 58.8% | 13.0% | 0.1 | 58.3 |
| 2019-2021  | 83.0% | 59.9% | 23.0% | 0.1 | 62.6 |
| 2020-2022  | -10.0% | 64.1% | -19.0% | 0.2 | 49.6 |
| 2021-2023  | -37.0% | 71.2% | -58.0% | 0.5 | 45.2 |
| 2022-2024  | -70.0% | 75.3% | -91.0% | 0.6 | 41.7 |
| 2023-2025  | -10.0% | 75.3% | -25.0% | 1.0 | 62.1 |


**2. Recent Price Movement:**

* **Closing Price:** $55.08
* **Previous Close:** $55.95
* **Daily Change:** -$1.55 (a -2.77% decrease)
* **5-Day Moving Average:** $55.07
* **20-Day Moving Average:** $49.41
* **60-Day Moving Average:** $46.04

The price is currently above its 20-day and 60-day moving averages, suggesting potential upward momentum, despite the recent daily decline.


**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.42 (Medium Risk)
* **RSI:** 68.8 (Approaching overbought territory, suggesting potential for a short-term pullback)
* **PPO:** 1.52 (Positive, indicating bullish momentum)
* **20-Day Relative Divergence Change:** +2.5 (Short-term upward trend)
* **Expected Return (2+ years):** -31.1% (This indicates a significant underperformance relative to the S&P 500 over the long term, based on current data. This requires careful consideration. )

The recent price drop (-$1.55) is noteworthy but not extreme enough to suggest a significant market event (e.g. a crash).


**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2024-10-24 | $0.8 | $4.61B      |
| 2024-07-25 | $0.74 | $4.40B      |
| 2024-04-29 | $0.15 | $4.02B      |
| 2023-10-26 | $0.20 | $2.49B      |
| 2024-10-24 | $0.20 | $2.49B      | *(Duplicate entry, likely a data error)*


Earnings show significant fluctuation.  EPS and Revenue seem to be improving in Q2 and Q3 2024 compared to the previous quarter, yet still significantly lower than Q1 2024. There is a discrepancy in the data with duplicated values that needs clarification.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $5.65B | 45.51%       |
| 2024-09-30 | $4.61B | 36.13%       |
| 2024-06-30 | $4.40B | 37.35%       |
| 2024-03-31 | $4.02B | 31.39%       |
| 2023-12-31 | $3.96B | 24.59%       |

**Capital and Profitability:**

| Quarter | Equity  | ROE    |
|---------|---------|--------|
| 2024-12-31 | $29.93B | 4.69%  |
| 2024-09-30 | $29.71B | 3.10%  |
| 2024-06-30 | $29.38B | 2.90%  |
| 2024-03-31 | $28.89B | 0.59%  |
| 2023-12-31 | $29.03B | -10.88% |

Financial data shows an upward trend in revenue and profit margins in recent quarters and a recovery in ROE.


**6. Overall Analysis:**

NEM shows a mixed picture. While recent financial data indicates improving profitability and a strong revenue performance in Q4 2024, the stock significantly underperformed the S&P 500 over the past period.  The high beta suggests significant market sensitivity.  Technical indicators are somewhat bullish (PPO positive, price above moving averages), but the RSI is approaching overbought levels.  The projected long-term underperformance (-31.1%) compared to the S&P 500 warrants caution.  More detailed analysis, including examination of the data discrepancies and a deeper understanding of the company's future prospects, is necessary before drawing definitive conclusions.  The high volatility of the stock should be considered carefully.
